share_log

HC Wainwright & Co. Reiterates Buy on GT Biopharma, Maintains $5 Price Target

Benzinga ·  Aug 8, 2023 06:28

HC Wainwright & Co. analyst Robert Burns reiterates GT Biopharma (NASDAQ:GTBP) with a Buy and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment